Semax
XASemax is a synthetic heptapeptide derived from a fragment of ACTH(4-10). It is widely used in neuropeptide and BDNF-expression research and is supplied as a lyophilised powder for in-vitro research only.
- CAS
- 80714-61-0
- Purity
- ≥98%
- Form
- Lyophilised powder
- Price
- On enquiry
Research contexts
- BDNF and neurotrophic factor expression studies
- Neuroprotection assay models
- Comparative research with Selank and amidate analogues
Listed for reference only. Nothing here describes, suggests or implies any use in humans or animals.
Handling and storage
Store lyophilised at -20 °C; keep reconstituted solution at 2-8 °C and protected from light.
Testing and documentation
Batch 2025-12 was analysed by Janoshik Analytical on 30 December 2025 at 99.596% purity. Report #98756 can be verified independently with key R8KL7VCZCS25.
Related compounds
Research use only. Supplied strictly for in-vitro laboratory research by qualified researchers. Not a therapeutic good, not for human or veterinary use, not for diagnostic purposes, and not for food or cosmetic manufacture. No claims of safety or efficacy are made or implied.